HIGHLIGHTS
MS treatments on the horizon?
Geneticists and Neuroscientists at CWRU School of Medicine have created a platform for discovering modulators of oligodendrocyte differentiation and myelination. This may be useful for developing drugs to turn a patient's own cells into myelinating cells to counter disease. The findings were published in the online September issue of Nature Methods. Please visit this article.
Restoring respiration after spinal cord injury
Neuroscience Professor Jerry Silver, and his postdoc Warren Alilain have published their work on functional regeneration of respiratory pathways after spinal cord injury. The article appeared in the July 2011 issue of Nature. For more information visit this article.
Neuroscience Chair named Distinguished University Professor
Please join us in congratulating Dr. Lynn Landmesser for receiving the Distinguished University Professor Award. Details are in the Case Daily. Dr. Landmesser has served as Chair of the Department of Neuroscience since 1999. Please visit her website.
MS Clinical Trial gaining momentum
A collaborative multiple sclerosis trial between CWRU, CCF, and UH has been recieving a lot of media attention lately. This exposure, and the fact that it is the first in N. America to use adult MSCs, has increased the number of interested study participants. Read the article in Medicus.
|
-
The Center pursues these goals through Translational Interest Group meetings and events, and through the Neurological Institute, in the University Hospitals Case Medical Center, where clinicians and investigators have a direct conduit between research and developing treatments.
|
